Meta-analysis of the correlation between P53 expression in breast cancer tissues and the efficacy of neoadjuvant chemotherapy also shows that P53 can be used as an indicator of the sensitivity of neoadjuvant chemotherapy for breast cancer [22]. The gene discussed is TP53; the disease is breast carcinoma.